Amplia uncovers new clue in pancreatic cancer drug trial

The Sydney Morning Herald - Oct 22, 2026

Amplia Therapeutics has advanced its cancer drug narmafotinib across four trials, with data suggesting it may work independently of common tumour-causing KRAS gene mutations.

Read full article

More News

Sign Up Now

Subscribe to us for the latest news from Banking Reporter

Banking Reporter

Banking Reporter is the largest-circulated online business news in the United States, bringing a whole new genre of business journalism more up close and more incisive.